Clinical Trial Detail

NCT ID NCT03483324
Title Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Angiocrine Bioscience
Indications

acute myeloid leukemia

acute lymphoblastic leukemia

acute leukemia

Therapies

AB-110

Age Groups: adult

No variant requirements are available.